ARCHIVES

ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals

This article is from The Cancer Letter archive.

Vol. 39 No. 35 | September 20, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Approves DNA Test For Two Types of HPV

March 27, 2009

DCPC Board Kills Cost Sharing for CIS, Rejects Primary Care Prevention Effort Evaluation Budget

May 13, 1988

Mendelsohn To Step Down As MD Anderson President

December 10, 2010

Leukemia Society, NCI, Discuss Funding, Congressional Language On Centers In

January 14, 1994

Proposed Criteria For Establishing Carcinogenicity Listed

November 21, 1975

ACS Asks Congress For $1.32 Billion NCI ’87 Budget

April 4, 1986